What Is the Future of MTEER?
Presenter
James M. McCabe, MD, FSCAI, The University of Washington, Seattle, WA
James M. McCabe, MD, FSCAI, The University of Washington, Seattle, WA
Learning Objectives:
- Understand whether MTEER is appropriate for lower-risk patients
- Understand whether MTEER may become obsolete when TMVR becomes mainstream
- Understand the rationale for the PRIMARY and REPAIR MR trials
Keywords: Structural Heart Disease (SHD) and TEER/TMVR/Mitral Valve